

Scientists think they may have uncovered a whole new approach to fighting antibiotic-resistant bacteria, which, if successful, would help address a health crisis responsible for more deaths every year than either AIDS or malaria.
Using cellphone mobility data and COVID-19 hospital admissions data, researchers at The University of Texas at Austin have reliably forecast regional hospital demands for almost two years, according to a new study published in the Proceedings of the National Academy of Sciences. The forecasting system, which municipal authorities credit with helping Austin maintain the lowest COVID-19 death rate among all large Texas cities, has been built out for use by 22 municipal areas in Texas and can be used by any city to guide COVID-19 responses as the virus continues to spread.

Expanding rapid testing stands out as an affordable way to help mitigate risks associated with COVID-19 and emerging variants. Infectious disease researchers at The University of Texas at Austin have developed a new model that tailors testing recommendations to new variants and likely immunity levels in a community, offering a new strategy as public health leaders seek a way out of a pandemic that has so far thwarted the best efforts to end its spread. It is the first study to identify optimal levels of testing in a partially immunized population.

Until COVID-19, few people alive today had experienced the chaos and destruction of a really bad pandemic, one that has at times ground businesses, schools and social lives to a near standstill and killed millions globally. But did you know that we aren't alone in being battered by a global infectious disease? Frogs are also struggling through their own pandemic that, according to biologist Kelly Zamudio, has several eerie parallels with COVID-19. Perhaps our own encounters with a pandemic will give us new sympathy for our slimy, bug-eyed friends.

UT Austin structural biologist Jason McLellan, Ph.D., is the recipient of the 2022 Edith and Peter O'Donnell Award in Medicine from TAMEST (The Academy of Medicine, Engineering and Science of Texas). He was chosen for his breakthrough research in mapping, modifying, and stabilizing coronavirus spike proteins, which paved the way for the creation of leading COVID-19 vaccines.


Few developments have rocked the biotechnology world or generated as much buzz as the discovery of CRISPR-Cas systems, a breakthrough in gene editing recognized in 2020 with a Nobel Prize. But these systems that naturally occur in bacteria are limited because they can make only small tweaks to genes. In recent years, scientists discovered a different system in bacteria that might lead to even more powerful methods for gene editing, given its unique ability to insert genes or whole sections of DNA in a genome.



Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic fever (CCHF). It causes death in up to 40% of cases, and the World Health Organization identified the disease as one of its top priorities for research and development. The results appear today in the journal Science.


Jason McLellan, UT Austin molecular biosciences professor, has received the 2021 Shirley Bird Perry Longhorn Citizenship Award, recognizing the wide-reaching impact of his work with viral proteins, especially his contributions to COVID-19 vaccines. The award is given annually by UT Austin's Annette Strauss Institute for Civic Life.